Literature DB >> 3455063

Single dose therapy with ivermectin for onchocerciasis.

B M Greene1, A T White, H S Newland, E Keyvan-Larijani, Z D Dukuly, M Y Gallin, M A Aziz, P N Williams, H R Taylor.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3455063

Source DB:  PubMed          Journal:  Trans Assoc Am Physicians        ISSN： 0066-9458


× No keyword cloud information.
  4 in total

Review 1.  Familiar dermatologic drugs as therapies for COVID-19.

Authors:  M Ortega-Peña; R González-Cuevas
Journal:  Actas Dermosifiliogr       Date:  2020-12-23

Review 2.  Empowering communities in combating river blindness and the role of NGOs: case studies from Cameroon, Mali, Nigeria, and Uganda.

Authors:  Stefanie E O Meredith; Catherine Cross; Uche V Amazigo
Journal:  Health Res Policy Syst       Date:  2012-05-10

3.  Potential Value of Triple Drug Therapy with Ivermectin, Diethylcarbamazine, and Albendazole (IDA) to Accelerate Elimination of Lymphatic Filariasis and Onchocerciasis in Africa.

Authors:  Peter U Fischer; Christopher L King; Julie A Jacobson; Gary J Weil
Journal:  PLoS Negl Trop Dis       Date:  2017-01-05

4.  A Reevaluation of the Tolerability and Effects of Single-Dose Ivermectin Treatment on Onchocerca volvulus Microfilariae in the Skin and Eyes in Eastern Ghana.

Authors:  Nicholas O Opoku; Michael E Gyasi; Felix Doe; Daphne Lew; Augustine R Hong; Sithembele Chithenga; Peter U Fischer; Christopher L King; Gary J Weil
Journal:  Am J Trop Med Hyg       Date:  2021-11-29       Impact factor: 2.345
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.